Skip to main content
. 2019 Jan 28;9(4):832–842. doi: 10.1016/j.apsb.2019.01.012

Figure 4.

Fig. 4

(A) miR21 gene down-regulation of anti-miR21 nanopompons in vitro. Asterisks (*) denote statistically significant differences (data represented as mean±SD, **P < 0.001, n = 3). (B) QRT-PCR and (C) Western blot result of the down-regulation at both mRNA and protein level of miR21 after treatment, bringing about up-regulation of two target genes PTEN and PDCD4 in vitro. (D) Cell viability test of DHA-nanopompon, nanopompon, DHA-PEG-pOEI and PEG-pOEI on 293 cells by MTT assay.